About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Analgesic Efficacy of Maxigesic in Breast Cancer Surgery

NCT06174363·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Jin Sun Cho
CONTACT
82-2-2228-2419 chjs0214@yuhs.ac

Lead

Yonsei University

Age

20–70

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Patient aged 20 to 70 years with ASA classification 1 to 3 undergoing breast cancer surgery (cancer resection or reconstruction)

You may not be if

ASA classification 4/ allergy to acetaminophen, NSAIDs, opioid/ severe liver or renal dysfunction/ pregnancy

The record

StatusRecruiting

PhaseNo phase

Taking part84

StartedDec 2023

UpdatedJul 20, 2025

Conditions

Where1

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine
Seoul, South Korea

Clareo Health | Analgesic Efficacy of Maxigesic in Breast Cancer Surgery